Journey of Coronavirus
It’s been six months since China first discovered the virus and reported a number of cases of mysterious pneumonia in Wuhan. A disease that merely started as another type of pneumonia quickly spread in Wuhan and more than 50,000 cases were recorded in Wuhan alone. Till now China has recorded a total of 85,399 cases in the last six months.
The virus that came to be known as SARS-CoV-2 quickly spread throughout the world, affecting almost every continent except Antarctica. From indigenous tribes in Amazon to already disease-stricken areas in Africa have been hit by the virus.
Since the outbreak of the virus SARS-CoV-2, there have been 10.4 million people infected around the globe with more than 500,000 people killed by the virus. Since then health workers are running around for protective gear, hospitals have been overwhelmed with sick patients and the whole world went into lockdown, stopping all activities of mankind.
In the past six months, the world experienced things it never thought it would. As one by one nations started getting affected by the virus, economies and societies shut down. Staying at home became heroic, masks and sanitizers became one of the most important things while leaving the house and people learned about social distancing and quarantine.
A Global Scientific Effort
The infection started an uncommon worldwide effort to discover antibodies and treatment. In the past half-year, there have been colossal logical advances, not least of which has been separating and sequencing the infection inside 12 days of the flare-up being reported to the Chinese Centers for Disease Control and Prevention (CDC). That implies that surprisingly fast, researchers made sense of that the infection is comprised of RNA and that its arrangement is made out of 29,900 letters, or bases, all arranged like a series of dots.
By February, researchers made sense of the structure of the “spike proteins” the infection uses to attack human cells. The spike proteins open a receptor or “entryway” into cells called ACE2. Since the receptors are found in a wide range of cell types over our bodies from the lungs to the heart, the infection can have broad effects on the body.
We found out much about how the infection shows clinically, the rundown of manifestations it causes — from hack and fever to queasiness to loss of taste and smell — is long and questionable and its the study of disease transmission and how it spreads.
We have also equipped ourselves with different ways to battle the infection. using non-pharmaceutical interventions to prevent infection has given hope to many.
A Sudden Pandemic Hit
Every nation had its reaction to the infection. A few spots, similar to the city of Wuhan in China, established severe lockdowns, banning the vast majority from leaving their homes. Different nations, similar to Sweden, scarcely positioned any limitations on society.
A few nations, like New Zealand, effectively disposed of the infection — in this round, at any rate — with early activity, reliable informing, and other powerful procedures. Others like the U.S. had a disorganized reaction that began with an apathetic demeanor and has just begun to consider resurgence to be the infection as an interwoven of states revived without clear plans set up for how to test, follow and seclude cases. “From multiple points of view, the Chinese took a slug for us, to give us a couple of additional months to get ready,” Rutherford said. “The Europeans did an OK work, but the U.S. did an extremely helpless activity.”
At the point, when the infection showed up in the U.S., the Centers for Disease Control and Prevention made a basic blunder by deciding to make its tests in-house, instead of depending on a World Health Organization (WHO) unit that was at that point created. At that point, labs around the nation couldn’t lead tests all alone, because the CDC units utilized a broken reagent that wasn’t creating dependable outcomes. Furthermore, there were “plenty of superfluous standards about testing,” Rutherford disclosed to Live Science. For example, one beginning rule necessitated that any individual who was tried have some association with Wuhan, China. “We missed a few of the early bunches that came in,” he included. The infection “gained out of power in the United States for an assortment of reasons, for the most part, which originated from the absence of administration.”
India has been one of the worst-hit nations, with more than 7 lakh cases in the last 4-5 months along. Though the death rate has been pretty low and majority cases have been recovered, there doesn’t seem to be an end to this pandemic. Many people have lost their jobs, along with economic difficulties and mental health issues due to isolation. India received its first coronavirus case in March and since then the curve has been constantly moving upward. Though the government has put in a lot of effort to control the spread no proper administrative planning has caused the infection to spread more rapidly when the country went under lockdown and a lot of the working population was stranded in different places with no means of food or transport.
Vaccines and Treatment
What do the following a half year hold? In a perfect world, we’ll have the first of the coronavirus antibodies in quite a while for health care workers and then for the public.
Toward the beginning of the episode in the U.S., Anthony Fauci, the executive of the National Institute of Allergy and Infectious Diseases, said it could take 12 months to a year and a half to have a SARS-CoV-2 immunization — which is quicker than any antibody has ever been created.
17 antibodies are at present in clinical preliminaries, as indicated by the WHO. Moderna’s trial antibody utilizes detachment RNA to prod the body to mount an insusceptible reaction to the coronavirus. Specialists at Oxford University in the United Kingdom are trying another immunization produced using a debilitating cold infection joined with qualities from the coronavirus and plan to have the main portions prepared by the fall.
A bunch of medicines for COVID-19 are as of now being used, however, none are blockbusters.
Gilead Science’s redeliver is right now the main medication approved by the Food and Drug Administration (FDA) to treat COVID-19 patients, after a clinical preliminary found that it altogether decreased the time it takes for patients to recover. Another enormous preliminary, in the United Kingdom, found that a basic and modest steroid, dexamethasone, can lessen mortality for patients who are utilizing oxygen or on a ventilator.
There are presently about 1,600 investigations being led worldwide on the coronavirus, a bunch of them testing possible antibodies on people, as indicated by the U.S. National Library of Medicine and the WHO.